Short Interest in AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Decreases By 99.6%

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) was the recipient of a significant decline in short interest in December. As of December 15th, there was short interest totaling 1,863 shares, a decline of 99.6% from the November 30th total of 511,837 shares. Based on an average daily trading volume, of 1,171,454 shares, the short-interest ratio is presently 0.0 days. Based on an average daily trading volume, of 1,171,454 shares, the short-interest ratio is presently 0.0 days.

AXIM Biotechnologies Price Performance

Shares of OTCMKTS:AXIM traded down $0.00 during midday trading on Wednesday, reaching $0.01. 34,900 shares of the company’s stock were exchanged, compared to its average volume of 317,961. The company’s 50 day simple moving average is $0.01 and its two-hundred day simple moving average is $0.01. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03.

AXIM Biotechnologies Company Profile

AXIM Biotechnologies, Inc is a development-stage biotechnology company focused on the research, development and commercialization of cannabinoid-based technologies. The company’s primary objective is to advance formulations and delivery systems for cannabidiol (CBD) and other cannabinoids, targeting applications in nutraceuticals, skincare and medical devices. Through its proprietary encapsulation and atomization techniques, AXIM aims to enhance the bioavailability and stability of cannabinoid compounds for consumer and clinical use.

The company’s product pipeline includes novel CBD-infused nutraceuticals designed to promote general wellness, as well as specialized formulations for topical and inhalation delivery.